Ben Lacey
MBChB MSc DPhil FFPH
Senior Clinical Research Fellow
Ben Lacey is a public health physician and epidemiologist. He is a Senior Clinical Research Fellow at UK Biobank, based at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford. His research is on large-scale observational epidemiology, focusing particularly on the design, conduct and analysis of large cohort studies of the determinants of chronic diseases. He is currently working on UK Biobank and on cohorts in Cuba, Mexico, Malaysia, and India. He studied medicine at the University of Edinburgh and undertook specialist training in public health in Oxford, during which time he received an MSc in Global Health Science and a DPhil in Epidemiology. He was made a Fellow of the Faculty of Public Health in 2012.
Recent publications
-
Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150 000 adults
Journal article
LACEY BEN., (2021), International Journal of Epidemiology
-
Social inequality, chronic disease and COVID-19: county-level analysis in the United States
Journal article
Islam N. et al, (2020), Journal of Epidemiology and Community Health
-
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Journal article
Roth GA. et al, (2020), Journal of the American College of Cardiology, 76, 2982 - 3021
-
Alcohol consumption and cause-specific mortality in Cuba: prospective study of 120 623 adults
Journal article
Rojas NA. et al, (2020), EClinicalMedicine
-
Authors' Reply: Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries
Other
Islam N. et al, (2020)
-
Five insights from the Global Burden of Disease Study 2019.
Journal article
GBD 2019 Viewpoint Collaborators None., (2020), Lancet, 396, 1135 - 1159
Research groups
- Accurately estimating the burden of vascular disease using electronic health records
- Adiposity, body fat distribution and risk of chronic disease in Asian and European populations
- Adiposity, COVID-19 and other infections in UK Biobank
- Analysing big data from electronic health records to understand the determinants of cardiovascular disease
- Deep phenotyping of vascular events in large-scale epidemiological studies using electronic health records
- Understanding and modelling the geographical variation in relative risks for smoking and other major risk factors for burden of disease analyses